Tevogen Inc. (TVGN): who owns it and who trades it
As of Nov 16, 2026, TVGN insiders reported 3 open-market sales worth $6.6K and no purchases in the last 12 months, with 0% of the sale value made under pre-set 10b5-1 plans. The largest seller was Neal Flomenberg (See Remarks), with $6.6K. 1 of the 50 famous funds we follow held it at their last quarter end.
Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.
At a glance
Who is buying and selling Tevogen
From the latest filingsOverall: about as much buying as selling. Insiders mostly sold. Famous investors mostly bought.
Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.
Insider trades
In the last 12 months, TVGN insiders reported $0 of open-market purchases and $6.6K of sales. 0% of the sale value was under a 10b5-1 plan, a schedule set up in advance.
Purchases and sales by month
Latest trades
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Mar 13, 2026 | Neal Flomenberg | See Remarks | Sale | 501 | $6.40 | $3.2K | Form 4 |
| Mar 11, 2026 | Neal Flomenberg | See Remarks | Sale | 452 | $7.26 | $3.3K | Form 4 |
| Mar 10, 2026 | Neal Flomenberg | See Remarks | Sale | 19 | $7.75 | $147 | Form 4 |
Insiders by value traded
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Neal Flomenberg | See Remarks | – | $6.6K | Mar 13, 2026 |
What this data shows, and what it doesn't
- Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
- Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
- "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
- Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
- Filings are self-reported and can be amended. Each trade links to its original filing. Methodology
TVGN short interest
Low short interest. 0.8% of TVGN shares are sold short: about 1 share in 119. Over the last 12 reports the number of shares short went down 54%.
As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.
As of Oct 30, 2026, 54,853 TVGN shares were sold short, 0.8% of the shares outstanding, down 1.0% from the report before. At the average daily volume of 12,670 shares, buying them all back would take about 4.3 trading days (days to cover).
Shares short, % of all shares
Days to cover
Every report
| Settlement date | Shares short | % of shares | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|---|
| Oct 30, 2026 | 54,853 | 0.84% | -1% | 12,670 | 4.3 |
| Oct 15, 2026 | 55,420 | 0.85% | -0% | 5,349 | 10.4 |
| Sep 30, 2026 | 55,589 | 0.85% | -5% | 5,255 | 10.6 |
| Sep 15, 2026 | 58,325 | 0.90% | -3% | 11,162 | 5.2 |
| Aug 31, 2026 | 60,116 | 0.92% | +2% | 5,757 | 10.4 |
| Aug 14, 2026 | 58,741 | 0.90% | -14% | 10,354 | 5.7 |
| Jul 31, 2026 | 68,546 | 1.65% | +6% | 15,020 | 4.6 |
| Jul 15, 2026 | 64,847 | 1.56% | -1% | 16,639 | 3.9 |
| Jun 30, 2026 | 65,388 | 1.57% | -21% | 26,388 | 2.5 |
| Jun 15, 2026 | 82,425 | 1.98% | -24% | 29,267 | 2.8 |
| May 29, 2026 | 108,916 | 2.62% | -9% | 45,040 | 2.4 |
| May 15, 2026 | 119,463 | 2.87% | +12% | 30,186 | 4.0 |
Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks
Tevogen company events
Tevogen filed 12 reports on Form 8-K in the last 12 months, 6 of them about an important change (leadership, listing). The latest was on Nov 4, 2026.
- Nov 4, 2026LeadershipSusan Podlogar gave notice of her resignation from service as a director of Tevogen Inc., effective immediately. Filing
- Nov 3, 2026LeadershipTevogen Inc. granted Ryan Saadi, Chief Executive Officer and Chairperson of the Company’s Board of Directors, a restricted stock award under the Tevogen Inc. 2024 Omnibus Incentive Plan, covering 50,000,000 shares of the Company’s common stock, par value $0.0001 per share. Filing
- Sep 30, 2026AnnouncementTevogen Inc. received written notice from The Nasdaq Stock Market LLC notifying the Company that it had regained compliance with the $50 million minimum market value of the listed securities requirement under Nasdaq Listing Rule 5450(b)(2)(A) for continued listing on The Nasdaq Global Market. Filing
- Sep 16, 2026LeadershipTevogen Inc. granted the Company’s executive officers restricted stock awards under the Tevogen Inc. 2024 Omnibus Incentive Plan, in each case consisting of shares of the Company’s common stock, par value $0.0001 per share, subject to terms and restrictions set forth in an RSA agreement with the… Filing
- Sep 10, 2026AnnouncementTevogen Inc. received written notice from The Nasdaq Stock Market LLC notifying the Company that it had regained compliance with the $15 million minimum market value of publicly held shares requirement under Nasdaq Listing Rule 5450(b)(2&3)(C) for continued listing on The Nasdaq Global Market. Filing
- Aug 26, 2026LeadershipTevogen Inc. held an annual meeting of its stockholders. Filing
- Jul 30, 2026RulesChanged its bylaws or articles. Filing
- Apr 22, 2026ListingTevogen Bio Holdings Inc. received a letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC notifying the Company that the Company no longer meets Nasdaq’s $50 million minimum market value for listed securities requirement pursuant to Nasdaq Listing Rule 5450(b)(2)(A) for… Filing
- Mar 25, 2026AnnouncementTevogen Bio Holdings Inc. received written notice from The Nasdaq Stock Market LLC notifying the Company that it had regained compliance with the minimum bid price requirement set forth in Nasdaq Listing Rule 5450(a)(1) for continued listing on The Nasdaq Global Market. Filing
- Mar 4, 2026SharesChanged the rights of its shareholders. Filing
- Feb 25, 2026LeadershipTevogen Bio Holdings Inc. held a special meeting of its stockholders. Filing
- Jan 30, 2026AnnouncementShared information with investors. Filing
From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week
Tevogen financials
Famous investors that hold TVGN
1 of the 50 well-known investors we track reported holding TVGN in their latest 13F filing. The largest position is Ken Griffin's, worth $111K.
| Fund | Quarter | Shares | Value | Of portfolio | Change |
|---|---|---|---|---|---|
| Ken Griffin · Citadel Advisors | Q3 2026 | 16,726 | $111K | 0.0% | New |
From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.
5%+ stakes filed in the last 120 days
Anyone who owns more than 5% of a company must report it on Schedule 13D or 13G. 2 filings named TVGN in the last 120 days.
| Filed | Holder | Form | Stake |
|---|---|---|---|
| Nov 4, 2026 | Saadi Ryan H. | 13D/A | 91.1% |
| Nov 4, 2026 | Saadi Ryan H. | 13D/A | 91.1% |
Questions about Tevogen Inc. (TVGN) stock
Are TVGN insiders buying or selling?
In the last 12 months, TVGN insiders reported no open-market purchases and 3 sales worth $6.6K. The latest trade was on Mar 13, 2026. See every trade.
What is the short interest in TVGN?
As of Oct 30, 2026, 54,853 TVGN shares were sold short, 0.8% of the shares outstanding, down 1.0% from the report before. At the average daily volume of 12,670 shares, buying them all back would take about 4.3 trading days (days to cover). See the history.
Which famous investors hold TVGN?
1 of the 50 well-known investors we track reported TVGN in their latest 13F filing, including Ken Griffin. The largest position is worth $111K. See all holders.
Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.